Previous Close | 3.7200 |
Open | 3.7300 |
Bid | 3.3000 x 900 |
Ask | 3.6500 x 1000 |
Day's Range | 3.5000 - 3.7400 |
52 Week Range | 1.9950 - 7.9600 |
Volume | |
Avg. Volume | 895,811 |
Market Cap | 287.495M |
Beta (5Y Monthly) | 1.06 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.0100 |
Earnings Date | Mar 04, 2024 - Mar 08, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 15.29 |
Subscribe to Yahoo Finance Plus to view Fair Value for OCUL
Key Insights Significantly high institutional ownership implies Ocular Therapeutix's stock price is sensitive to their...
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q3 2023 Earnings Call Transcript November 7, 2023 Ocular Therapeutix, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.27. Operator: Good day. Thank you for standing by. Welcome to the Third Quarter 2023 Ocular Therapeutix Earnings Conference Call. At this time, all participants are in a listen-only mode. After […]
BEDFORD, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences: Jefferies London Healthcare ConferenceFireside Chat Date: Wednesday, November 15, 2023Fireside Chat Time: 3:00 PM GMTLocation: Waldorf Hilton, London, UK BTIG 3rd Annual Ophthalmology D